Previously, we demonstrated that the triple-negative breast cancer cell line MDA-MB-468 exhibited reduced cell viability and active apoptosis after treatment with a CDK8 inhibitor [17]. The gene discussed is CDK8; the disease is triple-negative breast carcinoma.